About radar

This author has not yet filled in any details.
So far radar has created 66 blog entries.

Plasticell Spins Out Regenerative Drug Discovery Venture

New demerged business called ‘Progenitor Labs’ Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent £3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult™ technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery unit into a [...]

April 13th, 2011|Press Releases|

Plasticell completes £3.5 million financing round

Capital injection to expand business development and marketing initiatives Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced it has completed a two-part equity financing, raising a total of £3.5 million from new and existing investors. The first tranche of the financing, in which £1.5 million was drawn down in April 2009, was [...]

January 31st, 2011|Press Releases|

Plasticell signs technology agreement with Sigma-Aldrich

Collaboration to produce novel turnkey solution for stem cell research Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the signing of a collaboration agreement with Sigma-Aldrich, a leading provider of technologies and reagents to the life science research market. In the collaboration, Sigma-Aldrich will use its CompoZr® Zinc Finger Nuclease Technology to [...]

November 29th, 2010|Press Releases|

Plasticell signs screening collaboration with UCB. First in kind deal to partner small molecule drugs for stem cell research

Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB. Under the terms of the agreement, UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its award-winning CombiCult technology to discover new cell [...]

November 8th, 2010|Press Releases|

Plasticell launches second generation CombiCultTM screening platform Company wins Frost & Sullivan 2010 European Technology Innovation Award

London, UK, 12 October 2010 Plasticell, the biotechnology company specialising in high throughput screening for stem cell differentiation, announces the launch of its second generation CombicultTM 10,000-Plex Screen capable of rapidly screening up to ten thousand cell culture media combinations. At the same time, the company is pleased to announce that it has won the Frost & Sullivan 2010 European [...]

October 12th, 2010|News Articles|

Combinatorial Cell Culture™ patent granted in Europe and other regions

London, UK, 2 August 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that patents protecting its proprietary cell culture technology, Combinatorial Cell Culture™ (CombiCult™), have been granted by the European Patent Office, Australian Patent Office and Intellectual Property Office of Singapore. The granted patents cover high throughput and combinatorial methods of carrying out cell culture and exemplify [...]

August 2nd, 2009|News Articles|

Plasticell validates regenerative drug screen in collaboration with GSK

London, 12 March 2009 … Research announced today by Plasticell, a leading UK regenerative medicine biotech company, shows how embryonic stem cells can be used to discover novel small molecules capable of encouraging the body to regenerate, potentially paving the way for the development of drugs to repair organs damaged by disease or ageing. Plasticell used its proprietary technologies to [...]

March 12th, 2009|Press Releases|